![Adeana Dorsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adeana Dorsey
No open positions remaining
Profile
Adeana Dorsey is Vice President-Regulatory Affairs at TuHURA Biosciences, Inc. since 2024.
Former positions include Vice President-Regulatory Affairs at Akouos, Inc. in 2022, Director-Regulatory & Strategy Development at Clinipace, Inc. from 2019 to 2022, and Director-Chemistry, Manufacturing & Controls at Cardinal Health, Inc. from 2015 to 2018.
Education includes undergraduate studies at Marshall University.
Adeana Dorsey active positions
| Companies | Position | Start |
|---|
Former positions of Adeana Dorsey
| Companies | Position | End |
|---|---|---|
| AKOUOS | General Counsel | 2022-10-31 |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital contract research solutions | Corporate Officer/Principal | 2022-05-31 |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 2018-11-30 |
Training of Adeana Dorsey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital contract research solutions | Commercial Services |
Marshall University
 Marshall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
- Stock Market
- Insiders
- Adeana Dorsey
